MXPA03008423A - Agonistas del receptor nicotinico para el tratamiento de enfermedades inflamatorias. - Google Patents
Agonistas del receptor nicotinico para el tratamiento de enfermedades inflamatorias.Info
- Publication number
- MXPA03008423A MXPA03008423A MXPA03008423A MXPA03008423A MXPA03008423A MX PA03008423 A MXPA03008423 A MX PA03008423A MX PA03008423 A MXPA03008423 A MX PA03008423A MX PA03008423 A MXPA03008423 A MX PA03008423A MX PA03008423 A MXPA03008423 A MX PA03008423A
- Authority
- MX
- Mexico
- Prior art keywords
- receptor agonists
- treatment
- inflammatory diseases
- nicotinic receptor
- agonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Esta invencion se relaciona al uso de los agonistas del receptor de nicotina para tratar las enfermedades inflamatorias, incluyendo una variedad de enfermedades pulmonares. Tales agonistas tienen pocos efectos secundarios que otros farmacos anti-inflamatorios, tales como esteroides. Ademas, estos agonistas pueden ser utiles solos o en combinacion con otros farmacos anti-inflamatorios para aliviar las enfermedades pulmonares.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002341952A CA2341952A1 (en) | 2001-03-23 | 2001-03-23 | Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
PCT/CA2002/000412 WO2002076434A2 (en) | 2001-03-23 | 2002-03-25 | Nicotinic receptor agonists for the treatment of inflammatory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03008423A true MXPA03008423A (es) | 2004-03-19 |
Family
ID=4168679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03008423A MXPA03008423A (es) | 2001-03-23 | 2002-03-25 | Agonistas del receptor nicotinico para el tratamiento de enfermedades inflamatorias. |
Country Status (18)
Country | Link |
---|---|
US (3) | US7601720B2 (es) |
EP (1) | EP1370264B1 (es) |
JP (1) | JP4377586B2 (es) |
CN (1) | CN100528159C (es) |
AT (1) | ATE378051T1 (es) |
AU (1) | AU2002249023B2 (es) |
BR (1) | BR0208305A (es) |
CA (1) | CA2341952A1 (es) |
DE (1) | DE60223508T2 (es) |
DK (1) | DK1370264T3 (es) |
ES (1) | ES2295331T3 (es) |
IL (1) | IL157757A0 (es) |
MX (1) | MXPA03008423A (es) |
NO (1) | NO331674B1 (es) |
NZ (1) | NZ528042A (es) |
PL (1) | PL207880B1 (es) |
RU (1) | RU2299731C2 (es) |
WO (1) | WO2002076434A2 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8188043B2 (en) | 1999-07-28 | 2012-05-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine in therapeutic angiogenesis and vasculogenesis |
US20050130990A1 (en) * | 2001-03-23 | 2005-06-16 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
CA2341952A1 (en) | 2001-03-23 | 2002-09-23 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
US7045534B2 (en) * | 2002-02-12 | 2006-05-16 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of reducing angiogenesis |
US8039459B2 (en) | 2004-07-15 | 2011-10-18 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
US8557804B2 (en) | 2002-03-25 | 2013-10-15 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
US20040010018A1 (en) * | 2002-05-15 | 2004-01-15 | Rueter Lynne E. | Treatment of neuropathic pain |
US7238715B2 (en) | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
PL364348A1 (en) * | 2004-01-12 | 2005-07-25 | PHARMENA Sp.z o.o. | Application of quaternary pyridine salts as vessel protection agent |
RU2414461C2 (ru) * | 2004-07-15 | 2011-03-20 | Юниверсите Лаваль | Агонисты рецепторов никотина и способы их применения для лечения воспалительных заболеваний |
US8378109B2 (en) | 2004-12-07 | 2013-02-19 | The Regents Of The University Of California | Labeled ALPHA4BETA2 ligands and methods therefor |
US9029557B2 (en) | 2004-12-07 | 2015-05-12 | The Regents Of The University Of California | Labeled A4B2 ligands and methods therefor |
US8316104B2 (en) | 2005-11-15 | 2012-11-20 | California Institute Of Technology | Method and apparatus for collaborative system |
WO2007075720A2 (en) * | 2005-12-19 | 2007-07-05 | Comentis, Inc. | Topical mecamylamine formulations for ocular administration and uses thereof |
CA2651580C (en) * | 2006-05-08 | 2016-01-19 | Arturo Solis Herrera | The use of nicotine, nicotines analogues, precursors or derivatives in the treatment of various pathological processes |
EP3524246A1 (en) * | 2010-03-23 | 2019-08-14 | Philip Morris Products S.A. | Use of anatabine to treat inflammation and methods of synthesizing anatabine |
US8207346B2 (en) | 2010-03-23 | 2012-06-26 | Rock Creek Pharmaceuticals, Inc. | Methods of synthesizing anatabine |
US20130053355A1 (en) | 2011-08-29 | 2013-02-28 | Rock Creek Pharmaceuticals, Inc. | Products for anti-inflammation support |
CA2944226C (en) | 2014-04-03 | 2021-03-02 | Universite Laval | Method for use of homopiperazinium compounds in the treatment of cancer |
RU2593585C1 (ru) * | 2015-06-26 | 2016-08-10 | Общество с ограниченной ответственностью "Ритек-Фарма" | Способ лечения табакокурения и других форм никотиновой зависимости, а также профилактики рецидивов табакокурения |
CN113992687B (zh) * | 2021-12-28 | 2022-04-08 | 浙江宇视科技有限公司 | 智能业务集群调度方法、装置、电子设备及存储介质 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2594296A (en) * | 1948-06-24 | 1952-04-29 | Aerosol Corp | Lobeline aerosol dilating medicament |
US2778772A (en) | 1952-11-04 | 1957-01-22 | Parke Davis & Co | Dimethyl phenyl piperazinium iodide compositions and process for stimulation of the autonomic ganglion system |
US3402039A (en) | 1966-12-05 | 1968-09-17 | Dow Chemical Co | Piperazinium salts as plant stunting agents |
US5977144A (en) | 1992-08-31 | 1999-11-02 | University Of Florida | Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines |
AU3855995A (en) * | 1994-11-11 | 1996-06-06 | Nippon Soda Co., Ltd. | Optically active compound |
WO2000023062A2 (en) * | 1998-10-20 | 2000-04-27 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain and inflammation |
US5846983A (en) | 1996-02-09 | 1998-12-08 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
RU2127123C1 (ru) * | 1996-06-04 | 1999-03-10 | Московское производственное химико-фармацевтическое объединение им.Н.А.Семашко | Противоастматическое лекарственное средство в виде таблеток и способ получения таблеток |
GB9614902D0 (en) * | 1996-07-16 | 1996-09-04 | Rhodes John | Sustained release composition |
US5981549A (en) | 1997-02-14 | 1999-11-09 | Synapse Pharmaceutical International | Method for controlling or alleviating the symptoms of respiratory disease and allergies |
TR200001171T2 (tr) | 1997-10-27 | 2000-10-23 | Neurosearch A/S | Nikotinik asetilkolin reseptörlerinde kolinerjik ligandlar olarak heteroaril diazasikloalkalinler |
WO2000051637A1 (en) * | 1999-03-02 | 2000-09-08 | Centocor, Inc. | ANTI-TNFα ANTIBODIES IN THERAPY OF ASTHMA |
EP1202738A4 (en) | 1999-06-21 | 2002-08-14 | Bristol Myers Squibb Co | DIHYDROPYRAZINE DERIVATIVES AS NPY ANTAGONISTS |
SE0001075D0 (sv) * | 1999-09-01 | 2000-03-27 | Laszlo Bense | Användning av åtminstone ett nikotinbaserat ämne och/eller ett ur detta ämne framställt ämne för tillverkning av ett medikament samt förfarande för behandling av obstruktiva lungsjukdomar |
GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
US6610713B2 (en) | 2000-05-23 | 2003-08-26 | North Shore - Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
DE60132710T2 (de) | 2000-12-01 | 2008-06-12 | Neurosearch A/S | 3-substituierte chinuclidine und ihre verwendung als nikotinische agonisten |
US20020160988A1 (en) | 2001-02-20 | 2002-10-31 | Israel Institute For Biological Research | Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
CA2440763C (en) | 2001-03-22 | 2010-05-25 | Battelle Memorial Institute | Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles |
CA2341952A1 (en) | 2001-03-23 | 2002-09-23 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
US20050130990A1 (en) | 2001-03-23 | 2005-06-16 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
GB2381750A (en) | 2001-10-10 | 2003-05-14 | Inspire Pharmaceuticals Inc | Treatment for enhancing joint lubrication |
US20030236287A1 (en) | 2002-05-03 | 2003-12-25 | Piotrowski David W. | Positive allosteric modulators of the nicotinic acetylcholine receptor |
TW200412945A (en) | 2002-10-25 | 2004-08-01 | Upjohn Co | Quaternary ammonium compounds |
MXPA05004586A (es) | 2002-10-29 | 2005-07-26 | Pharmacia & Upjohn Co Llc | Compuestos de amonio cuaternario. |
AU2003267796A1 (en) | 2002-10-29 | 2004-05-25 | Pharmacia & Upjohn Company Llc | Quaternary ammonium compounds |
US20050075323A1 (en) | 2003-03-05 | 2005-04-07 | Pfizer Inc | Beta3 adrenergic receptor agonists and uses thereof |
FR2852830B1 (fr) | 2003-03-24 | 2008-04-18 | Oreal | Composition de teinture des fibres keratiniques comprenant un derive de para-phenylenediamine cationique substitue par un cycle diazacyclohexane ou diazacycloheptane |
EP1622606A1 (en) | 2003-04-15 | 2006-02-08 | Pharmacia & Upjohn Company LLC | Quaternary ammonium compounds and their use as antimuscarinic agents |
RU2414461C2 (ru) | 2004-07-15 | 2011-03-20 | Юниверсите Лаваль | Агонисты рецепторов никотина и способы их применения для лечения воспалительных заболеваний |
-
2001
- 2001-03-23 CA CA002341952A patent/CA2341952A1/en not_active Abandoned
-
2002
- 2002-03-25 IL IL15775702A patent/IL157757A0/xx not_active IP Right Cessation
- 2002-03-25 WO PCT/CA2002/000412 patent/WO2002076434A2/en active IP Right Grant
- 2002-03-25 ES ES02717896T patent/ES2295331T3/es not_active Expired - Lifetime
- 2002-03-25 JP JP2002574950A patent/JP4377586B2/ja not_active Expired - Fee Related
- 2002-03-25 BR BR0208305-1A patent/BR0208305A/pt not_active IP Right Cessation
- 2002-03-25 NZ NZ528042A patent/NZ528042A/en not_active IP Right Cessation
- 2002-03-25 RU RU2003131178/14A patent/RU2299731C2/ru not_active IP Right Cessation
- 2002-03-25 DE DE60223508T patent/DE60223508T2/de not_active Expired - Lifetime
- 2002-03-25 PL PL365224A patent/PL207880B1/pl unknown
- 2002-03-25 CN CNB028071387A patent/CN100528159C/zh not_active Expired - Fee Related
- 2002-03-25 AU AU2002249023A patent/AU2002249023B2/en not_active Ceased
- 2002-03-25 AT AT02717896T patent/ATE378051T1/de active
- 2002-03-25 MX MXPA03008423A patent/MXPA03008423A/es active IP Right Grant
- 2002-03-25 US US10/469,999 patent/US7601720B2/en not_active Expired - Fee Related
- 2002-03-25 DK DK02717896T patent/DK1370264T3/da active
- 2002-03-25 EP EP02717896A patent/EP1370264B1/en not_active Expired - Lifetime
-
2003
- 2003-09-19 NO NO20034185A patent/NO331674B1/no not_active IP Right Cessation
-
2009
- 2009-09-03 US US12/553,574 patent/US20100227871A1/en not_active Abandoned
-
2011
- 2011-06-15 US US13/161,035 patent/US8377936B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60223508T2 (de) | 2008-09-25 |
NZ528042A (en) | 2005-10-28 |
PL207880B1 (pl) | 2011-02-28 |
CN100528159C (zh) | 2009-08-19 |
CA2341952A1 (en) | 2002-09-23 |
US20110245270A1 (en) | 2011-10-06 |
IL157757A0 (en) | 2004-03-28 |
ATE378051T1 (de) | 2007-11-15 |
EP1370264A2 (en) | 2003-12-17 |
CN1498108A (zh) | 2004-05-19 |
NO20034185L (no) | 2003-11-24 |
ES2295331T3 (es) | 2008-04-16 |
WO2002076434A3 (en) | 2003-07-17 |
JP2004523588A (ja) | 2004-08-05 |
AU2002249023B2 (en) | 2006-02-02 |
RU2299731C2 (ru) | 2007-05-27 |
US7601720B2 (en) | 2009-10-13 |
WO2002076434A2 (en) | 2002-10-03 |
DK1370264T3 (da) | 2008-03-17 |
DE60223508D1 (de) | 2007-12-27 |
PL365224A1 (en) | 2004-12-27 |
JP4377586B2 (ja) | 2009-12-02 |
US20040132737A1 (en) | 2004-07-08 |
NO331674B1 (no) | 2012-02-20 |
NO20034185D0 (no) | 2003-09-19 |
BR0208305A (pt) | 2004-03-09 |
EP1370264B1 (en) | 2007-11-14 |
RU2003131178A (ru) | 2005-04-10 |
US8377936B2 (en) | 2013-02-19 |
US20100227871A1 (en) | 2010-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03008423A (es) | Agonistas del receptor nicotinico para el tratamiento de enfermedades inflamatorias. | |
IN2005DE03350A (es) | ||
TW200608979A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
HK1149764A1 (es) | ||
PT1202736E (pt) | Nicotina na angiogénese e vasculogénese terapêuticas | |
MXPA06014510A (es) | Composiciones y metodos para tratar trastornos inflamatorios. | |
TW200637522A (en) | Skin treatment articles and methods | |
TW200738724A (en) | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
UA85597C2 (ru) | Четвертичные соли как антагонисты ccr2 | |
MY142067A (en) | Xanthine derivatives as selective hm74a agonists, processes for the manufacture of said derivatives, formulations comprising these derivatives, and their use in the treatment of diseases where under-activation of the hm74a receptor contributes to the disease | |
TW200633980A (en) | Pyridones useful as inhibitors of kinases | |
TW200510416A (en) | P38 inhibitors and methods of use thereof | |
TW200740787A (en) | (6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones | |
MY144616A (en) | Substituted dihydroquinazolines | |
TW200621765A (en) | Substituted phenylaminothiazoles and their use | |
MXPA03005340A (es) | Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida. | |
TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
AU7226301A (en) | Pyridoxine and pyridoxal analogues: cardiovascular therapeutics | |
TNSN07263A1 (en) | Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them | |
WO2002072571A3 (en) | Pyridinyl pyrazoles useful for the treatment of copd | |
HK1112228A1 (en) | Substituted azachinzolines having an antiviral action | |
WO2007100430A3 (en) | Cytisine and acetylcholine analogs and methods of treating mood disorders | |
TW200635920A (en) | Pyrazinedicarboxamides and their use | |
UA95780C2 (en) | Xanthine derivatives as selective hm74a agonists | |
DK1100824T3 (da) | Forbindelser med væksthormonfrigivende egenskaber |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |